Healius is one of Australia’s leading healthcare companies providing high quality, accessible and cost-efficient healthcare services in Pathology and Diagnostic Imaging, employing 11,000+ over 2,200 locations.
Healius Pathology is one of Australia’s leading providers of private medical laboratory and pathology services, Healius Pathology operates 97 medical laboratories and approximately 2,000 patient collection centres across metropolitan, regional, and remote Australia. A team of over 200 specialist pathologists and 6,000 scientists, technicians, collectors are dedicated to delivering affordable and accessible healthcare nationwide.
Through a variety of established state-based and specialty brands, including QML, Laverty, Dorevitch, Western Diagnostics, Abbott and TML, Healius Pathology provides leading medical laboratory and pathology services across key diagnostic activities. Including anatomical, clinical, genetics and veterinary pathology.
Each year, Healius Pathology provides one in every three pathology services in Australia. These services extend from exclusively servicing some of Australia’s largest and most complex private and public hospitals to regional areas and remote Australian Aboriginal communities.
In January 2022, Healius acquired Agilex Biolabs, Australia’s largest, most experienced and scientifically advanced bioanalytical laboratory with over 25 years’ experience in clinical trials.
Headquartered in Adelaide, Agilex Biolabs provides bioanalytical services for therapeutics, immunoassay bioanalysis of large molecules, biologics and vaccine development. With its extensive experience, Agilex is well positioned for growth in multiple therapeutic areas including oncology, which is the largest market for clinical trials.